Partial deep dermal and full thickness burns

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Dec 2024Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

CUTISS AG — PHASE3

TrialRECRUITING
Oct 2017Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

CUTISS AG — PHASE2

TrialACTIVE NOT RECRUITING
Oct 2017Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

CUTISS AG — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Partial deep dermal and full thickness burns.
Check the disease page for updates →

Approved Treatments

2 FDA-approved

NexoBrid

(anacaulase-bcdb)Orphan drugstandard

Vericel Corporation

12.1 Mechanism of Action The mixture of enzymes in NEXOBRID dissolves burn wound eschar. The specific components responsible for this effect have not ...

FDA label ↗

StrataGraft

(allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat)Orphan drugstandard

Stratatech Corporation, a Mallinckrodt company

View full treatment details on disease page →

Clinical Trial Landscape

3 active trials
1Phase 3
2Phase 2
3Total recruiting
Search clinical trials for Partial deep dermal and full thickness burns

Recent News & Research

No recent news articles indexed yet for Partial deep dermal and full thickness burns.
Search PubMed for Partial deep dermal and full thickness burns

Browse all Partial deep dermal and full thickness burns news →

Specialist Network

Top 2 by expertise

View all Partial deep dermal and full thickness burns specialists →

Quick Actions